baxter report solid outlook match
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jan
estim
price data jan
rate updat jan
currenc amount express
methodolog valu compani
constant-curr growth adjust
oper margin basi point last
year fourth quarter baxter end fiscal
slightli ahead expect compani
outlook constant-curr revenu growth
adjust oper margin fall near
forecast therefor dont anticip major chang
fair valu estim updat model
baxter still linger issu deal
clari warn
letter on-going pressur
cyclophosphamid still encourag underli
perform busi new product innov
remain headwind pharmaceut divis
expect mid-single-digit growth baxter
segment leav narrow moat rate
baxter clinic nutrit medic deliveri
segment fell slightli forecast fourth
quarter strong result pharmaceut advanc
surgeri segment kept overal growth larg step
expect clinic nutrit medic
deliveri segment neg flat constant-
currenc sale respect continu face linger
effect note previou quarter suppli disrupt
relat hurrican maria expect perform
gradual improv segment especi
compani face easier year-over-year comparison
manag also note longer sale cycl infus
pump custom delay purchas even though baxter
believ gain increment share
baxter segment sale better expect
pharmaceut segment growth benefit new
product launch healthi demand anesthesia
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
busi segment renal segment sale includ hemodialysi
periton dialysi product acut therapi sale also
focus near-term kidney issu patient medic deliveri
sale includ iv pump solut pharmaceut sale
consist primarili inject drug anesthet gase compound
servic nutrit sale includ parenter nutrit therapi
advanc surgeri sale mostli incorpor hemostasi product
biosurg sealant contract manufactur servic round
roughli remain sale
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
compound servic anticip competit
cyclophosphamid brevibloc sale
million respect quarter like make
quarter segment growth difficult sustain
temporari benefit competitor suppli constraint help
boost growth recothrom lead growth
advanc surgeri lastli renal segment sale growth
match expect manag note high-
single-digit pd growth unit state off-set
declin sale less profit blood line product
result baxter focu profit busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
